LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.98 | 84.90 | 2609 | 7257 | 0.3595 | 0.7053 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 94.68 | 84.90 | 1583 | 7000 | 0.2261 | 0.5835 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 94.68 | 84.90 | 2043 | 7000 | 0.2918 | 0.6482 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 94.68 | 84.90 | 2643 | 7000 | 0.3776 | 0.7162 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 94.68 | 84.90 | 2657 | 7000 | 0.3796 | 0.7177 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 2.66 | 84.90 | 556 | 285 | 1.9458 | 1.9251 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 2.66 | 84.90 | 450 | 285 | 1.5749 | 1.5923 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 4.36 | 84.90 | 655 | 322 | 2.0306 | 1.8891 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 4.36 | 84.90 | 577 | 322 | 1.7888 | 1.7050 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 6.06 | 84.90 | 727 | 365 | 1.9893 | 1.7725 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 6.06 | 84.90 | 652 | 365 | 1.7841 | 1.6328 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.77 | 84.90 | 819 | 411 | 1.9915 | 1.7069 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.77 | 84.90 | 733 | 411 | 1.7824 | 1.5781 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 9.47 | 84.90 | 874 | 447 | 1.9534 | 1.6442 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 9.47 | 84.90 | 805 | 447 | 1.7992 | 1.5551 | MN20160318_Q02 | F10 |